ROYAL BANK OF CANADA - CHINA BIOLOGIC PRODS INC ownership

CHINA BIOLOGIC PRODS INC's ticker is CBPOXXXX and the CUSIP is 16938C106. A total of 115 filers reported holding CHINA BIOLOGIC PRODS INC in Q2 2017. The put-call ratio across all filers is 0.26 and the average weighting 0.3%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of CHINA BIOLOGIC PRODS INC
ValueSharesWeighting
Q2 2017$16,034,000
+12.9%
141,774
-0.0%
0.01%0.0%
Q1 2017$14,198,000
-6.9%
141,787
-0.1%
0.01%0.0%
Q4 2016$15,255,000
-13.6%
141,879
+0.0%
0.01%
-20.0%
Q3 2016$17,659,000
+81.4%
141,863
+55.0%
0.01%
+66.7%
Q2 2016$9,733,000
+243225.0%
91,549
+326860.7%
0.01%
Q4 2015$4,000
-76.5%
28
-88.8%
0.00%
Q4 2014$17,000
+30.8%
2500.0%0.00%
Q3 2014$13,000
+225.0%
250
+150.0%
0.00%
Q2 2014$4,0001000.00%
Other shareholders
CHINA BIOLOGIC PRODS INC shareholders Q2 2017
NameSharesValueWeighting ↓
WARBURG PINCUS LLC 10,989,200$1,049,578,0007.88%
RUDMAN ERROL M 110,201$10,525,0003.65%
Ativo Capital Management LLC 59,789$5,710,0002.24%
OBERWEIS ASSET MANAGEMENT INC/ 56,200$5,368,0001.51%
Granite Point Capital Management, L.P. 40,000$3,820,0001.40%
Cormorant Asset Management, LP 76,500$7,307,0001.13%
Spark Investment Management LLC 52,800$5,031,0000.70%
Grandeur Peak Global Advisors, LLC 33,050$3,157,0000.67%
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC 198,454$18,954,0000.66%
Visium Asset Management, LP 438,008$41,834,0000.62%
View complete list of CHINA BIOLOGIC PRODS INC shareholders